Clinical Conversations

This podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.

Posts Tagged ‘Michael Mauer’

July 10th, 2009

Podcast 49: Three RASS Study researchers discuss their findings on the lack of benefit of renin-angiotensin blockade in the primary prevention of diabetic nephropathy in Type 1 diabetes.

We talk with Drs. Michael Mauer, Ronald Klein, and Bernard Zinman about their paper in the July 2 New England Journal of Medicine reporting on the RASS study (Renin-Angiotensin System Study). They found that blockade of the renin-angiotensin system was not effective in the primary prevention of diabetic nephropathy in Type 1 diabetes. This week’s […]

Categories: diabetes type 1, nephropathy, renin-angiotensin blockade
Tags: ACE inhibitors, ARBs, aspirin, Bernard Zinman, Darvocet, Darvon, diabetes, diabetic nephropathy, diabetic retinopathy, dronedarone, famotidine, Michael Mauer, propoxyphene, RASS study, renin-angiotensin blockade, Ronald Klein

About the Podcast

Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.